August 28, 2013 / 10:30 AM / 4 years ago

China's Simcere to be taken private by Chairman for $495 mln

Aug 28 (Reuters) - China's Simcere Pharmaceutical Group said it agreed to be bought by a consortium that includes its founder-chairman Jinsheng Ren in a deal worth $495.4 million.

The company said it will receive $9.66 per American depositary share (ADS), representing a premium of about 3 percent over Tuesday's close on the New York Stock Exchange.

The consortium already owns about 78 percent of Simcere's outstanding shares and had made an offer worth $9.56 per ADS to buy the company on March 11.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below